leucine-rich repeat serine/threonine-protein kinase 2; dardarin (LRRK2, PARK8)

From Aaushi
Jump to navigation Jump to search

Function

Structure

Compartment

Expression

Pathology

More general terms

Additional terms

References

  1. UniProt http://www.uniprot.org/uniprot/Q5S007.html
  2. 2.0 2.1 George J. Genetic Mutation Slows Motor Symptoms in PD. Research could inform trials of new anti-Parkinson's disease drugs. MedPage Today January 11, 2018 https://www.medpagetoday.com/neurology/parkinsonsdisease/70438
    Saunders-Pullman R, Mirelman A, Alcalay RN et al Progression in the LRRK2-Asssociated Parkinson Disease Population. JAMA Neurol. Published online January 8, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29309488 https://jamanetwork.com/journals/jamaneurology/article-abstract/2668463

Database